Doctor Mitchell posted a brief history of cannabis and

New Post Public Reply Private Reply Replies (0) Message Board
Kgem
298
Doctor Mitchell posted a brief history of cannabis and where we are today this morning. I assume this is in preparation for his meeting with law makers on September 11, 2019.

Cannabis Greater Than and Less Than

Words are vitally important when you decide to tell a story. Words have to match the audience you are writing to. This is a short story about Cannabis. First, you have to make sure that your audience understands what subject you are writing on if a new subject. So, an explanation might be necessary if it is a new subject which may not be an everyday subject matter. Cannabis is one of those subjects which has come into recent prominence with a lot of misunderstanding mainly because of the words people use, that do not tell the correct history and story.

The proper name for Cannabis is Cannabis sativa L. I will go with the short version Cannabis. It is an important annual herbaceous flowering plant indigenous to eastern Asia but now has a cosmopolitan distribution due to widespread cultivation over 100 years. Cannabis has had a long and sometimes bumpy history which extends from China 5000 BC to the new world of the Americas 1620 AD in its making and landing on our shores with the pilgrim’s arrival.

Cannabis has been cultivated throughout recorded history and used as a source for three main reasons, fiber, seeds or oil. Its extended use history includes food, recreational moods, religious and spiritual moods and medicine. The plant fell into American disfavor in the early 20th century when it was vilified and labeled as a poison in the 1930s and criminalized in the 1970s. The reasons for Cannabis disfavor are another rabbit hole for another blog at another time!

The Cannabis debate was fueled with word selection going back to the 1937 Marijuana Tax Act. The word Cannabis was substituted for this word, Marijuana, which was Spanish in origin and misspelled in English, Marihuana. Cannabis had already been in our US medicine cabinets for almost 100 years, so this name change was very important to title the bill with specific direction, however, the name Marijuana is not mentioned in the body of the 1937 bill. The word Cannabis sativa L was imprinted, by name, which would freeze both general application for industrial and/or medical purposes. When you could not pronounce the Spanish or English rendition of this new word then other names were given, Weed, Pot, Mary Jane, etc.

The recurrent debate over Cannabis caught fire when the 1970 War on Drugs ignited a debate on whether to look at this plant as two different plants, one for industrial purposes and the other plant as a medicine or drug. The confusion on the government’s part went back and forth. While that was concussing and a flip flop occurred multiple times in the Halls of Justice. Here come the important words. Cannabis is cannabis!

Each part of this same plant, Cannabis sativa L can be grown and harvested for different purposes, depending on its end use outlined in the third paragraph. The species was first classified by a word "sativa" which means things that are cultivated. What was not understood or clear was when the chemical properties in this plant changed to a point where it became subject to abuse. It was 1906 that Cannabis was called a poison and classified as a narcotic via the Uniform State Narcotic Drug Act, where 35 states had it listed as such. The Marihuana Tax Act of 1937 demonetized this crop with this expensive tax levy and trade embargo. Growing the Cannabis crop came to a halt and medical research stopped.

The 1937 tax act did not make Cannabis illegal. However, the whole plant was then criminalized and made illegal with the 1970 Controlled Substances Act and denoted as a Schedule 1 drug like heroin and cocaine. Well, fast forward to 2018. The slow crawl back into its rightful status as an incredible botanical got relief with the signing of the 2018 Farm Bill. Once again, The Farm Bill divided the plant back into two categories, Cannabis with Greater than 0.3% by weight, and Cannabis with Less than 0.3% by weight. The greater than 0.3% is still illegal and the less than 0.3% is in a renaissance for its medicinal remedies and the subject of my next blog. So, get your wording correct, with greater than and less than, so we all know what story you are telling.


Eric I. Mitchell MD.






Scroll down for more posts ▼

Top 10 Most Recent News Articles

IBM's Sports Tech Challenge Crowns AI Innovator LivXP

Updated Category News Views 18

Pioneering AI for Fan Engagement The big leagues of sports tech are buzzing, as IBM has just announced LivXP as the standout winner of their Sports Tech Startup Prize Challenge at the dynamic Web Summit Lisbon 2026. If there's one thing to remember, it's that this isn't just any accolade. This is a nod from IBM—an institution that's rubbed elbows with the giants of...

Continue Reading
Skilled Nursing: The Backbone of Comprehensive Care

Updated Category News Views 17

Crucial Crossroads: Hospital to Home Some stories don't come with ticker symbols or stock rises. Sometimes, we're sifting through what really matters—like Terry Esterline's rundown on skilled nursing and rehab services in Hillsdale, Michigan. This isn't about making a quick buck, it's about what helps people rebuild after a hospital stay. The Nuts and Bolts of Skilled...

Continue Reading
Nauticus Schedules 2026 Q3 Earnings Call; Key Insights Await

Updated Category News Views 100

Word on the street is that Nauticus Robotics is gearing up to dish out their third quarter earnings on November 17, 2026. If you're eyeballing the stock, NASDAQ:KITT, this might be your show. Autonomy in the subsea world isn't just about flashy tech—it's about getting investors to buy into the vision. These folks are turning waves into action with robots that perform...

Continue Reading
HLTH 2026: AI's Role in Couples Therapy Unveiled

Updated Category News Views 14

Testing AI's Place in the Therapy Room AI's getting more action in therapy sessions than it ever dreamed, and it’s high time we asked who benefits and who loses. Slotting in next to human therapists, AI like OurRitual’s Ora isn't about to steal the whole show, but it sure knows how to play a supporting role. At the HLTH 2026 conference, Dr. Orna Guralnik and OurRitual...

Continue Reading
DAN, GPRO, PSNL Deals Under Investor Scrutiny

Updated Category News Views 266

Behind the Curtain: What Do These Deals Mean for Shareholders? Sometimes, investing in a stock ain't just about numbers on a screen—it's about untangling the whole messy ball of yarn these companies hand you with a smile. We're looking at Dana Incorporated (NYSE: DAN), GoPro, Inc. (NASDAQ: GPRO), and Personalis, Inc. (NASDAQ: PSNL). They've all got deals on the table,...

Continue Reading
Baidu Faces Securities Suit Deadline This Week

Updated Category News Views 74

Deadline Looms Large for Baidu Investors Well, here we are again, dealing with another securities class action. If you've got your money parked in Baidu (NASDAQ:BIDU), the clock is ticking, and it's time to pay attention. November 13, 2026, is creeping up fast, and that could be a serious point of no return. What's the Buzz About? Faruqi & Faruqi, LLP, a heavyweight in...

Continue Reading
FIS Under Investigation: Legal Woes Hit Shareholders

Updated Category News Views 55

When Forecasts Falter: A Reality Check for FIS Investors You ever get the feeling a company is just a bit too optimistic? Well, Fidelity National Information Services, Inc. (NYSE: FIS) might've been playing that game up until its recent fiscal hiccup. The mess started on November 4, 2026, when FIS decided to slash its fiscal 2026 adjusted EPS outlook. From a Wall Street...

Continue Reading
Millrose Faces Class Action for Alleged Deception

Updated Category News Views 124

A Surprising Turn for Millrose Properties Nobody's grumbling over their coffee as much as Millrose Properties' investors these days. The company, traded under NYSE:MRP, is facing a securities class action lawsuit that'll make even the steeliest fund managers flinch. You see, this isn't just any lawsuit—it's a slap in the face of those who thought they were backing a...

Continue Reading
Frasle Mobility's Resilience Despite Market Woes in 3Q26

Updated Category News Views 125

Economic Wrangling: What Happened? Here comes Frasle Mobility, standing tall against a tide trying to pull everyone under. Ending the third quarter of 2026, they dropped a modest net revenue of R$1.38 billion. A light dip of 1.9% year-over-year, but don't let that fool you. Amid the chaos, these folks managed to expand their gross margin and kept their financials...

Continue Reading
MY DR NOW Challenges 9-to-5 with New Clinics

Updated Category News Views 12

Revolutionizing Healthcare Access Latte in one hand and the other hand tapping your steering wheel, trying to squeeze in that elusive doctor’s appointment between work meetings. Sound familiar? Well, those days might just be numbered. MY DR NOW is shaking up the traditional 9-to-5 doctor’s office stereotype by opening two new clinics that’ll stand sentinel seven...

Continue Reading

Top 5 Most Recently Viewed Articles

Immunocore Unveils Promising Data for Brenetafusp in Ovarian Cancer

Updated Category News Views 129

Immunocore Takes Key Steps with Brenetafusp Immunocore, a biotechnology firm dedicated to creating innovative immunomodulating treatments, has revealed important findings from the Phase 1 trials of brenetafusp, an ImmTAC bispecific that targets PRAME in ovarian cancer patients who are resistant to platinum therapy. These results were shared at a notable medical...

Continue Reading
Santhera and Ikris Pharma Join Forces for AGAMREE® in India

Updated Category News Views 216

Santhera Partners with Ikris for AGAMREE® Distribution Pratteln, Switzerland – Santhera Pharmaceuticals (SIX: SANN) has recently formed a pivotal agreement with Ikris Pharma Network to distribute AGAMREE® (vamorolone) in India. This exclusive partnership is dedicated to providing a treatment option for Duchenne muscular dystrophy (DMD) in children four years and...

Continue Reading
Orchid Island Capital Highlights August Dividend and Portfolio Insights

Updated Category News Views 183

Orchid Island Capital Declares August Monthly Dividend Orchid Island Capital, Inc. (NYSE: ORC), a prominent player in the specialized finance sector, has declared a monthly cash dividend of $0.12 per common share for August. This dividend is scheduled for distribution on September 29, keeping with the company’s commitment to returning value to its shareholders. Dividend...

Continue Reading
Mercari Japan App Debuts in U.S.: A Shopping Shift

Updated Category News Views 15

A New Frontier for Cross-Border Shopping There's a fresh wind blowing for collectors and Japan enthusiasts in the U.S. as Mercari Japan rolls out a new standalone app on American soil. Designed to streamline the hunt for Japanese treasures, it’s a bold play to solidify Mercari’s position as a cross-border e-commerce powerhouse. Maybe they’ve seen the writing on the...

Continue Reading
Franklin Access Receives Financing for Groundbreaking Sigbeat Venture

Updated Category News Views 195

Franklin Access Secures New Funding for Innovative Sigbeat Joint Venture Franklin Access (NASDAQ: FKWL) is thrilled to announce that it has successfully secured funding for its strategic joint venture to develop cutting-edge 4G/5G modules and artificial intelligence (AI) solutions under the Sigbeat brand. This significant milestone marks a transformative step towards...

Continue Reading